More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-14 of 14 results

  • www.chiesimedical.co.uk
  • 1
  • 1
In recognition of our commitment to sustainability, Chiesi is proud to have been recognised as a certified B Corp®, a business that strives to meet the highest social, legal and environmental standards to balance purpose and profit. B Corp®..
Relevance: 81.43868
  • retavase.com
  • 1
  • 2
Have questions? For additional assistance or questions not answered on this website, contact Chiesi USA, Inc... RETAVASE can cause significant and sometimes fatal bleeding. In a trial of 2,965 patients administered RETAVASE, the overall rate of in-..
Relevance: 46.01456
  • chiesirarediseases.com
  • 5
  • 3
  • 12
Chiesi is the largest global pharmaceutical group to be awarded B Corp Certification, a recognition..... Chiesi Global Rare Diseases is a family-owned and run biopharmaceutical company with a commitment to providing transformative care to patients..
Relevance: 45.34566
  • chiesitotalcare.com
©Chiesi USA, Inc. 2023. All rights reserved. Elfabrio® is a registered trademark of CHIESI FARMACEUTICI S.p.A.Ferriprox® is a registered trademark of CHIESI FARMACEUTICI S.p.A. Lamzede® is a registered trademark of CHIESI FARMACEUTICI S.p.A.Revcovi®..
Relevance: 44.950096
  • cleviprex.com
CLEVIPREX-a dihydropyridine calcium channel blocker-can provide blood pressure (BP) reduction in the perioperative setting and in case of acute severe hypertension. CLEVIPREX is a ready-to-use option and has a 1-minute half-life... Access resources..
Relevance: 43.0104
  • www.chiesifoundation.org
  • 1
  • 1
  • 3
Chiesi Foundation Onlus is a non-profit organization founded in 2005, as an expression of the social responsibility of Chiesi Farmaceutici, whose aim is to improve the health and alleviate the suffering of patients, suffering from respiratory..
Relevance: 43.0104
  • rethinkfabry.com
Early diagnosis and starting treatment as early as possible may reduce symptoms and slow the course of disease... What is "mild" fabry disease? Women living with Fabry Explore your Fabry care team Fabry and your family... What we know about Fabry..
Relevance: 41.32483
Relevance: 40.54457
Relevance: 33.661438
  • www.chiesiair.co.uk
We're committed to helping patients with respiratory conditions, and we've been living this commitment for over 40 years... Find information for patients, carers and healthcare professionals covering Chiesi's medicines for asthma and chronic..
Relevance: 30.59664
  • www.lamzede.com
  • 1
Lamzede is an enzyme replacement therapy (ERT) for patients with alpha-mannosidosis-a long-awaited treatment for your patients and their loved ones. 1..
Relevance: 17.891088
  • retavase.com
  • 1
  • 2
RETAVASE is a tissue plasminogen activator (tPA) indicated for treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure... The only fixed-dose fibrinolytic for acute STEMI, RETAVASE is a recombinant..
Relevance: 17.524477
  • kengreal.com
  • 2
  • 2
KENGREAL® (cangrelor) is an injection of cangrelor. See benefits risks... In CHAMPION PHOENIX, KENGREAL provided significant risk reduction vs clopidogrel in the composite outcome of MACE (death, MI, IDR, and ST) at 48 hours, and the individual..
Relevance: 16.036674
Relevance: 11.910348